bibliographic resource 4253967 [br/4253967]
https://w3id.org/oc/corpus/br/4253967
- is a
-
- title
-
- A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-